Sotalol
- IV / OralSotalol
Mechanism of Action
- Binds to and inhibits potassium channels responsible for repolarisation in phase 3 of the cardiomyocyte action potential, thus increasing the absolute refractory period (ARP).
Clinical Use
- Indications
- Acute management of ventricular tachycardia
- Severe refractory tachyarrhythmias - Wolff-Parkinson-White / supraventricular tachycardia, atrial fibrillation / flutter
- Adverse Effects
- Elevated LFTs
- Torsade de pointes
- Bradycardia
- Hypotension
- Hypo / Hyperthyroidism
- Extrapyramidal effects